Ergasheva Gulshan Tokhirovna. BREAKTHROUGH THERAPIES IN TYPE 2 DIABETES: ADVANCED ROLE OF GLP-1 RECEPTOR AGONISTS AND SGLT2 INHIBITORS. imjrd [Internet]. 2026 Apr. 20 [cited 2026 Apr. 22];13(4):882-5. Available from: https://www.ijmrd.in/index.php/imjrd/article/view/5715